Because of the reduced K16 expression associated with loss of RHBDF2 and a thinner epidermis, the authors examined K16 expression in the skin of human TOC patients using immunohistochemistry and observed a considerable increase in K16 expression. Here, KRT16 is linked to palmoplantar keratoderma-esophageal carcinoma syndrome.